Morgan Stanley Starts Biogen (BIIB) at Overweight
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $193.18 -0.48%
Rating Summary:
29 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
29 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Morgan Stanley initiated coverage on Biogen (NASDAQ: BIIB) with an Overweight rating.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $311.78 yesterday.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $311.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Lowered to $270 at Oppenheimer
- Canaccord Genuity Starts Pan African Resources PLC (PAF:LN) at Buy
- Loop Capital Starts MongoDB (MDB) at Buy, '2H Ramp Ahead'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
